Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

New National Study Shows Strong, Bipartisan Support to Make Rapid COVID-19 Testing Free and Widely Available

Nationwide survey by COVID Collaborative, Harvard T.H. Chan School of Public Health and Hart Research shows overwhelming bipartisan support for at-home or venue-based low-cost rapid antigen tests

Consumer demand supports Biden Administration's deployment of rapid antigen tests to reopen the economy while vaccination is underway


News provided by

COVID Collaborative

Feb 24, 2021, 00:01 ET

Share this article

Share toX

Share this article

Share toX

WASHINGTON, Feb. 24, 2021 /PRNewswire/ -- COVID Collaborative and Harvard T.H. Chan School of Public Health, today released a first-of-its-kind national poll announcing that 86% of Americans say they would test themselves using at-home rapid antigen tests to stop the spread of COVID-19.

According to the poll conducted by Hart Research, an equal percentage of Americans support the use of rapid tests as part of a national strategy to reopen the economy, demonstrating that rapid testing is a public health tool that can play a major role in the country's economic recovery before widespread vaccination takes effect. An overwhelming majority of Americans (85%) support the federal government paying for and deploying rapid antigen tests as a way to reopen the economy, including 94% of Democrats and 74% of Republicans.

"As the Biden Administration and Congress consider scaling up rapid testing through the proposed $1.9 trillion American Rescue Plan, we thought it was important to understand the consumer demand among the American public," says Steven Phillips, MD, MPH, Vice President of Science and Strategy at the COVID Collaborative. "We learned that people are willing and eager to test themselves regularly at-home or upon entrance to public venues to keep their loved ones safe, stop the spread of COVID-19 and reopen America safely."

The nationwide survey of 1,569 adults found that across gender, age, race and ethnicity, education and political and employment categories, cost plays a key role in Americans' willingness to get frequent rapid tests. If the test costs $1, 79% of Americans would test themselves regularly at home. This drops to only 33% if the cost was $25—the current cost of the only FDA-approved at-home rapid test. 

If the testing is free—as it could be in a government program—most Americans approve of requiring antigen tests in a variety of out-of-home situations to reopen the economy, schools and our society safely, including at U.S. borders (92%), in schools (83%), at sports venues (81%), at workplaces (79%), at entertainment venues (79%) and for public transportation (74%). 

"Testing needs to be frequent, fast and accessible in order to help end the pandemic and get the economy back on track," explains Dr. Michael Mina, assistant professor of epidemiology at Harvard Chan School. "Rapid antigen tests detect individuals when they are most contagious. We can dramatically reduce the number of cases in the U.S. if there is a strategic deployment of rapid antigen tests so that infectious individuals know their status and can isolate or take behavioral precautions before spreading to others."

The Biden Administration is prioritizing at-home rapid antigen tests as a major policy pillar demonstrated by the recent procurement contracts with several manufacturers. In order for rapid testing to serve as an effective public health intervention to curb the pandemic, experts believe that upwards of 30 million tests per day need to be distributed to homes and venues strategically and effectively.

Despite some price sensitivity, the survey found that rapid antigen tests are highly appealing for their low cost, quick results and convenience. Strong majorities see getting results in 15 minutes (87%), low cost (87%), not having to wait in line (86%) or risk exposure at testing sites (85%) as important reasons to use rapid antigen tests at home. Privacy is also an important factor as 82% support rapid testing because it can be done in the privacy of their own home.

The survey also found that at-home rapid testing is popular among groups who are generally less supportive of traditional public health interventions promoted to curb the COVID-19 pandemic. For example, 45% of people who live in small towns/rural areas claimed to oppose regular COVID-19 testing. Yet when asked about testing themselves using rapid antigen tests, 81% would test themselves at home using at-home rapid antigen tests. Similarly, 49% of Republicans claim to oppose regular COVID-19 testing, but when asked, 79% of this group would test themselves using at-home rapid antigen tests.

Individuals who test positive on a rapid test said they would take precautions to keep their loved ones safe. The survey found that 78% of Americans would report a positive test result to local public health authorities, 86% would consult a medical professional and 87% would get a PCR confirmation test. Individuals would also stay home (94%), isolate from family members (93%), wear a mask (90%) and make sure household members/close contacts get tested (90%).

"We need to start putting the public back in public health," argues former Governor Dirk Kempthorne, CO-Chair of the COVID Collaborative. "The traditional public health methods of test, trace and isolate only work if testing is done frequently and results are known quickly. If we can make rapid testing available for use at home and in other venues, we know that infected individuals are willing to make safe and healthy choices. We will identify more infectious individuals before they spread to others and ultimately see a dramatic reduction in cases."

When pressed about obstacles to widespread adoption of rapid tests, Americans' greatest concern is accuracy. In the survey, 36% of adults characterized accuracy as a big concern and 44% called it somewhat of a concern. This demonstrates the opportunity to educate the public on the usefulness of rapid antigen tests for public health screening purposes. Rapid antigen tests are extremely effective in detecting COVID-19 when individuals are transmitting live virus, regardless of symptoms, which is all that matters to stop community transmission.1 It is frequency and speed of results—not absolute sensitivity of the test—that is most important for population screening.2

Frequent, rapid testing is one of the most underutilized public health interventions available to us today. One year into the pandemic, 9 in 10 think that COVID-19 is still a serious problem in the U.S. and 44% of those think that the worst is still ahead. Specifically, 77% of Americans worry about themselves or a family member getting COVID-19. In addition to masks, social distancing and vaccination, 80% of Americans believe testing is an important tool in tackling COVID-19 and getting the economy and American life to a new state of normalcy.

"The pandemic has inflicted the worst economic crisis on the United States since the Great Depression, but we can't get the economy back on track without first controlling the virus," said James Stock, professor of economics at Harvard University and former member of President Obama's Council of Economic Advisers from 2013-2014. "Frequent, rapid testing through at-home tests and entrance screening will make schools, workplaces and travel safer, bring back jobs and revenue and jump-start the economic recovery."

The COVID Collaborative is a national assembly for the COVID-19 crisis, bringing together leading experts in health, education, and the economy to support and empower state and local leaders to take unified action to turn the tide on the pandemic. https://www.covidcollaborative.us/ 

1 The New England Journal of Medicine, "Rethinking Test Sensitivity" Michael J. Mina, M.D., Ph.D., Roy Parker, Ph.D., and Daniel B. Larremore, Ph.D., November 26, 2020
2 Science Advances, "Test Sensitivity is Secondary to Frequency and Turnaround Time for COVID-19 Results"  Larremore, et al, January 1, 2021

SOURCE COVID Collaborative

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.